Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Appian Schedules Second Quarter 2020 Financial Results Conference Call and Will Present at Upcoming Investor Conferences
-
Troilus Provides Update on New Field Exploration Underway and Major Technical Milestones
-
Apple (AAPL) PT Raised to $444 at Canaccord Genuity As 5G Cycle Nears
-
Atreca (BCEL) Prices 7.031 Class A Share Common Offering at $16/Sh
-
Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock
-
Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock
-
Platinex Inc. Completes Non-Brokered Private Placement and Acquires Mining Claims and Royalties From Treasury Metals Inc.
-
Phunware Refinances Senior Convertible Note
-
Northern Dynasty Announces Closing of US$35.3 Million Bought Deal
-
Atalaya Mining PLC Announces Q2 2020 Operations Update
-
Net Asset Value(s)
-
Jamf Announces Launch of Initial Public Offering
-
Jamf Announces Launch of Initial Public Offering
-
BigCommerce Announces Filing of Registration Statement for Proposed Initial Public Offering
-
BioNTech (BNTX) PT Raised to $75 at Canaccord Genuity
-
iAnthus Announces Execution of Support Agreement for a Recapitalization Transaction
-
Protech Home Medical to Virtually Attend the Canaccord Genuity 40th Annual Growth Conference on August 11th – 13th
-
Protech Home Medical to Virtually Attend the Canaccord Genuity 40th Annual Growth Conference on August 11th – 13th
-
Zymeworks (ZYME) PT Raised to $42 at Canaccord Genuity
-
Transaction in Own Shares
-
Euro Manganese Announces Closing of First Tranche of Private Placement
-
Net Asset Value(s)
-
electroCore to Participate in Three Upcoming Virtual Investor Conferences
-
Curaleaf Announces Participation at Upcoming Financial Conferences & Events
-
Five9, Inc (FIVN) PT Raised to $130 at Canaccord Genuity; High Conviction Idea, with Major AT&T Partnership
-
SpineGuard Posts H1 2020 Revenue
-
Atalaya Mining PLC Announces Grant of Share Options and Director Shareholding
-
VAALCO Energy (EGY) Regains Compliance With NYSE Continued Listing Standards
-
VAALCO Energy, Inc. Regains Compliance With NYSE Continued Listing Standards
-
Saudi Arabia completes first phase of state mills privatisation
-
Regeneron Pharma (REGN) PT Raised to $700 at Canaccord Genuity on $450M BARDA COVID-19 Grant
-
Ascendis Pharma (ASND) Prices 4.225M ADS Offering at $14/ADS
-
Ascendis Pharma A/S Announces Pricing of Public Offering of ADSs
-
Treasury Metals Closes Over-Subscribed $11.5 Million Bought Deal Financing
-
Allegiant Gold Announces Closing of $3,000,000 Non-Brokered Private Placement
-
Euro Manganese Announces C$3.85 Million Private Placement and Board Restructuring
-
Euro Manganese Announces C$3.85 Million Private Placement and Board Restructuring
-
Sustainable Innovation & Health Dividend Fund Files Initial Public Offering
-
Planet 13 Announces Closing of C$11.5 Million Bought Deal Public Offering
-
Castle Biosciences Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
Ultragenyx Pharma (RARE) PT Raised to $91 at Canaccord Genuity
-
Qualcomm (QCOM) PT Raised to $115 at Canaccord Genuity
-
Neoleukin Therapeutics (NLTX) Prices 3.26M Share Common Offering at $15.25/Sh
-
Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering
-
Neoleukin Therapeutics Announces Pricing of $76.2 Million Public Offering
-
Canaccord Genuity Starts Moog (MOG-A) at Hold
-
Neoleukin Therapeutics (NLTX) Announces 5M Share Proposed Public Offering
-
Neoleukin Therapeutics Announces Proposed Public Offering
-
Neoleukin Therapeutics Announces Proposed Public Offering
-
Total voting rights

